前列腺癌雄激素剥夺治疗期间的身体成分：降低心血管风险的一个靶点。 - Suppr

Suppr

超能文献

Body Composition During Androgen Deprivation Therapy in Prostate Cancer: A Target to Reduce Cardiovascular Risk.

作者信息

Lee Jie, Lin Jhen-Bin

机构信息

Department of Radiation Oncology, MacKay Memorial Hospital, Taipei, Taiwan.

Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.

出版信息

JACC CardioOncol. 2024 Oct 15;6(5):772-774. doi: 10.1016/j.jaccao.2024.08.004. eCollection 2024 Oct.

DOI:10.1016/j.jaccao.2024.08.004

PMID:39479328

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11520197/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/11520197/de5f670bb28b/ga1.jpg

相似文献

Body Composition During Androgen Deprivation Therapy in Prostate Cancer: A Target to Reduce Cardiovascular Risk.前列腺癌雄激素剥夺治疗期间的身体成分：降低心血管风险的一个靶点。

JACC CardioOncol. 2024 Oct 15;6(5):772-774. doi: 10.1016/j.jaccao.2024.08.004. eCollection 2024 Oct.

Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.接受雄激素剥夺治疗的前列腺癌患者循环卵泡刺激素水平与身体组成及骨骼健康的关系：BLADE研究

Elife. 2024 Apr 24;13:e92655. doi: 10.7554/eLife.92655.

Cardiovascular risks of androgen deprivation therapy.雄激素剥夺疗法的心血管风险。

Arq Bras Cardiol. 2010 Sep;95(3):412-5. doi: 10.1590/s0066-782x2010001300019.

The effects of androgen deprivation therapy on lipid metabolism and body composition in Japanese patients with prostate cancer.雄激素剥夺疗法对日本前列腺癌患者脂代谢和身体成分的影响。

Jpn J Clin Oncol. 2011 Apr;41(4):577-81. doi: 10.1093/jjco/hyr005. Epub 2011 Feb 4.

Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.接受雄激素剥夺治疗的前列腺癌男性患代谢综合征、糖尿病和心血管疾病的风险增加。

Pharmacotherapy. 2008 Dec;28(12):1511-22. doi: 10.1592/phco.28.12.1511.

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.雄激素剥夺治疗期间的糖尿病和心血管疾病：前列腺癌退伍军人的观察性研究。

J Natl Cancer Inst. 2010 Jan 6;102(1):39-46. doi: 10.1093/jnci/djp404. Epub 2009 Dec 7.

Risk of cardiovascular intervention after androgen deprivation therapy in prostate cancer patients with a prior history of ischemic cardiovascular and cerebrovascular disease: A nationwide population-based cohort study.前列腺癌患者既往有缺血性心血管和脑血管疾病史后行雄激素剥夺治疗的心血管介入风险：一项基于全国人群的队列研究。

Urol Oncol. 2022 Jan;40(1):6.e11-6.e19. doi: 10.1016/j.urolonc.2021.07.002. Epub 2021 Jul 24.

Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.新诊断雄激素剥夺治疗-naive 前列腺癌男性的低血清睾酮及其与心血管危险因素的关系：RADICAL-PC 亚研究。

J Urol. 2022 May;207(5):1020-1028. doi: 10.1097/JU.0000000000002384. Epub 2022 Jan 3.

Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer.前列腺癌男性雄激素剥夺治疗的心血管风险及种族影响综述

Cancers (Basel). 2023 Apr 15;15(8):2316. doi: 10.3390/cancers15082316.

Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer.前列腺癌雄激素剥夺治疗的代谢和心血管风险

Expert Rev Endocrinol Metab. 2010 Jul;5(4):531-537. doi: 10.1586/eem.10.35.

引用本文的文献

Androgen Deprivation Therapy-Induced Muscle Loss and Fat Gain Predict Cardiovascular Events in Prostate Cancer Patients.雄激素剥夺疗法引起的肌肉流失和脂肪增加可预测前列腺癌患者的心血管事件。

J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13844. doi: 10.1002/jcsm.13844.

本文引用的文献

Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes.前列腺癌男性的肥胖与肌肉力量及心血管结局

JACC CardioOncol. 2024 Sep 3;6(5):761-771. doi: 10.1016/j.jaccao.2024.07.011. eCollection 2024 Oct.

Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.多学科干预在预防雄激素剥夺治疗的前列腺癌患者代谢综合征和改善身体成分方面的疗效：系统评价和荟萃分析。

Clin Nutr ESPEN. 2023 Dec;58:27-49. doi: 10.1016/j.clnesp.2023.09.001. Epub 2023 Sep 6.

Profiling of Skeletal Muscle and Adipose Tissue Depots in Men with Advanced Prostate Cancer Receiving Different Forms of Androgen Deprivation Therapy.接受不同形式雄激素剥夺治疗的晚期前列腺癌男性患者骨骼肌和脂肪组织库的分析

Eur Urol Open Sci. 2023 Sep 22;57:1-7. doi: 10.1016/j.euros.2023.09.004. eCollection 2023 Nov.

Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.接受前列腺放射治疗的男性的身体成分与死亡率：NRG/RTOG 9406 和 NRG/RTOG 0126 的汇总分析。

Cancer. 2023 Mar 1;129(5):685-696. doi: 10.1002/cncr.34596. Epub 2022 Dec 29.

Muscle Loss During Androgen Deprivation Therapy Is Associated With Higher Risk of Non-Cancer Mortality in High-Risk Prostate Cancer.雄激素剥夺治疗期间的肌肉损失与高危前列腺癌患者非癌症死亡风险增加相关。

Front Oncol. 2021 Sep 17;11:722652. doi: 10.3389/fonc.2021.722652. eCollection 2021.

Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis.脂肪和肌肉质量与前列腺癌男性患者总生存的相关性：系统评价与荟萃分析。

Prostate Cancer Prostatic Dis. 2022 Apr;25(4):615-626. doi: 10.1038/s41391-021-00442-0. Epub 2021 Aug 21.

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。

CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.

Machine Learning-Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival.基于机器学习的前列腺癌生存中非线性交互的解释与可视化。

JCO Clin Cancer Inform. 2020 Jul;4:637-646. doi: 10.1200/CCI.20.00002.

Muscle-Organ Crosstalk: The Emerging Roles of Myokines.肌肉-器官相互作用：肌动蛋白的新作用

Endocr Rev. 2020 Aug 1;41(4):594-609. doi: 10.1210/endrev/bnaa016.

Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer.前列腺癌患者开始雄激素剥夺治疗时进行锻炼以增强肌肉力量和身体功能的时机。

Prostate Cancer Prostatic Dis. 2020 Sep;23(3):457-464. doi: 10.1038/s41391-019-0200-z. Epub 2020 Feb 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验